Back to news overview

PharmaFluidics gets top investors on board

The biotech investors Rudi Mariën en Annie Vereecken invest money in VUB spin-off PharmaFluidics, following a capital round of more than €7 million. Mariën is seen as the uncrowned king of biotech. Vereecken, just like Mariën a pharmacist, became a great entrepreneur and invests a lot in biotech.

Click here to read the article in De Tijd.